Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2025-12-28 @ 9:14 PM
Study NCT ID:
NCT01722968
Status:
COMPLETED
Last Update Posted:
2019-02-27
First Post:
2012-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Biomarker Study in Patients With HER2-negative Metastatic Breast Cancer Treated With Bevacizumab and Paclitaxel
Sponsor:
Theodoros Foukakis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11
Start Date Type:
None
Primary Completion Date:
2018-06
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2012-10-22
First Submit QC Date:
None
Study First Post Date:
2012-11-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-25
Last Update Post Date:
2019-02-27
Last Update Post Date Type:
ACTUAL